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Feature Review
Autophagy in the regulation of
pathogen replication and adaptive
immunity
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2Viral Immunobiology, Institute of Experimental Immunology, University of Zu¨rich, Winterthurerstrasse 190, CH-8057 Zu¨rich,
Switzerland
Autophagy is an evolutionarily conserved homeostatic
process by which cells deliver cytoplasmic material for
degradation into lysosomes. Autophagy may have
evolved as a nutrient-providing homeostatic pathway
induced upon starvation, but with the acquisition of
cargo receptors, autophagy has become an important
cellular defence mechanism as well as a generator of
antigenic peptides for major histocompatibility complex
(MHC) presentation. We propose that autophagy effi-
ciently protects against microbes encountering the cy-
tosolic environment accidentally, for example, upon
phagosomal damage, whereas pathogens routinely
accessing the host cytosol have evolved to avoid or even
benefit from autophagy.
Selective autophagy for innate and adaptive immunity
Autophagy comprises a set of evolutionarily conserved
cytoplasmic degradation pathways that deliver cytosolic
constituents to lysosomes [1,2]. These include chaperone-
mediated autophagy, and micro- and macroautophagy.
While chaperone-mediated autophagy and microauto-
phagy import substrates directly into lysosomes, macro-
autophagy engulfs its substrates into double-membrane
vesicles, called autophagosomes. These autophagosomes
fuse subsequently with lysosomes or late endosomes for
degradation of their cargo. Macroautophagy is the only
known mechanism for cells to dispose of cytosolic compo-
nents too large for proteasomal degradation. Originally
thought a nonselective process, autophagosomes are now
recognised also to engulf substrates selectively, including
damaged organelles and protein aggregates but also bac-
teria, parasites and virions. Pathogens that invade the
cytosolic compartment as part of their regular life cycle
must therefore avoid, or at least inhibit, selective autop-
hagy to establish infection. By contrast, pathogens that
encounter autophagy sporadically, for example vesicle-
dwelling pathogens released into the cytosol from acciden-
tally damaged vesicles, are more likely to be restricted by
autophagy in their ability to colonise the cytosol. However,
as is true for most evolutionarily conserved defence mech-
anisms, certain pathogens have evolved the ability to
overcome autophagy or even take advantage of this path-
way, for example, to gain access to specific cellular com-
partments. Recently, some of the mechanisms that target
pathogens for autophagy have been revealed [3–5]. By
targeting cytosolic pathogens for lysosomal destruction,
macroautophagy contributes to the ability of cells to pres-
ent pathogen-derived peptides to T cells. Autophagy is
therefore an important contributor to both innate and
adaptive immunity.
In this review we will discuss the mechanisms of selec-
tive macroautophagy of pathogens and its contribution to
innate and adaptive immunity. We will also provide sev-
eral examples of how certain bacteria and viruses are
restricted by macroautophagy, whereas others escape
autophagy and sometimes even use this pathway for their
propagation. It therefore appears that pathogens not
adapted to life in the cytosol are efficiently restricted by
macroautophagy, whereas those with a cytosolic lifestyle
have evolved to avert autophagy or even subvert it for their
benefit.
Molecular mechanisms of autophagosome formation
Before discussing selective macroautophagy of pathogens,
we will introduce some aspects of the molecular machinery
underlying this process. Thirty-five genes have been identi-
fied as essential for macroautophagy in yeast [6], which
are called autophagy-related genes or atgs. During autop-
hagosome formation in either yeast or mammals, a mem-
brane is marked with phosphatidylinositol-3-phosphate
[PtdIns(3)P; PI3P] by a complex of the type III PI3 kinase
Vps34 (vacuolar protein sorting 34), in complex with Vps15,
ATG6/BECLIN-1 (Bcl-2-interacting protein 1) and ATG14L.
At the PI3P marked site, membrane elongation results in
the formation of an isolation membrane (also known as a
phagophore), which eventually closes around the substrate
into a completely sealed autophagosome (Figure 1). Autop-
hagosome formation in all eukaryotes requires two ubiqui-
tin-like systems that act sequentially. The first system
comprises the conjugation of the ubiquitin-fold protein
ATG12 to ATG5, catalysed by the E1- and E2-like enzymes
ATG7 and ATG10. ATG5–ATG12 associates with ATG16L1
into an E3-like enzyme that mediates the covalent
attachment of ATG8 (LC3B being the primarily studied
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mammalian homologue) to phosphatidylethanolamine (PE)
in the isolation membrane. Prior to this coupling event,
ATG8 requires C-terminal processing by the protease
ATG4 and activation by the E1- and E2-like enzymes
ATG7 and ATG3, respectively. Lipidated ATG8 facilitates
tethering and fusion of vesicular membranes and, therefore,
could promote elongation of the isolation membrane [7–9].
In addition, ATG8/LC3 is involved in anchoring substrates
to the inside of the emerging autophagosome. Once the
autophagsome is completed, it rapidly fuses with lysosomes
in a Rab7 (Ras-related in brain)-dependent fashion (half-life
of 10–25 min in hepatocytes). This fusion is also facilitated
by a PI3 kinase-containing ATG6/BECLIN-1 complex, pos-
sibly in conjunction with UVRAG (UV radiation resistance-
associated gene) and negatively regulated by Rubicon (RUN
domain protein as Beclin 1 interacting and cysteine-rich
containing). The de novo formation of autophagosomes
enables macroautophagy to engulf structures of variable
sizes, for example, protein aggregates, cell organelles or
whole pathogens, and accordingly autophagosomes can
range from 0.5 to 10 mm in diameter.
The membrane source for autophagosome formation is
still heavily debated. Isolation membranes have been visua-
lised by electron tomography on the rough endoplasmic
reticulum (rER) [10,11], but membranes of autophagosomes
are also found to originate from the Golgi apparatus,
the plasma membrane or mitochondria [12]. For selective
autophagy, particularly if involving pathogens occurring in
unforeseen places, the substrate might determine the loca-
tion where phagophores must form. The above-described
molecular machinery may therefore deploy membranes
already existing in close proximity to the pathogen to
initiate the formation of the isolation membrane. This flex-
ibility of autophagosome formation, both in size and loca-
tion, is used by the immune system to engulf invading
pathogens for degradation and antigen presentation, as well
as by pathogens to generate membrane structures that are
useful to them. In addition to the capture of pathogens by
canonical autophagy, ATG proteins are also deployed, either
individually or in small modules, to fight intracellular
pathogens in alternative pathways that do not involve
the formation of autophagosomes (discussed later in the
review).
Macroautophagy in innate immunity
Pathogen restriction by macroautophagy
Bacteria enter cells either passively by phagocytosis or
actively by inducing their uptake into normally nonpha-
gocytic cells, for example, through specialised secretion
apparatuses that inject bacterial effector proteins directly
into the host cytosol. Although most phagocytosed bacteria
are safely killed upon delivery into lysosomes, many intra-
cellular pathogens have evolved the ability to manipulate
vesicle maturation, allowing them to either proliferate
inside the vesicular compartment or to escape into the
cytosol. In an attempt to prevent infection, cells deploy
macroautophagy and LC3-associated phagocytosis (LAP;
discussed in detail later) to capture bacteria during their
inwards journey, followed by delivery into lysosomes for
destruction (Figure 2). In contrast to LAP, which modifies
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Figure 1. Restriction of pathogens by macroautophagy and their escape. Autophagosomes are formed with the help of two ubiquitin-like systems (ATG8/LC3 and ATG12)
and their formation and degradation is guided by phosphatidylinositol-3 (PI3) kinase complexes. The ATG8/LC3 ligase complex ATG5–ATG12–ATG16L1 conjugates ATG8/
LC3 to the isolation membrane or phagophore and is then recycled from the outer autophagosomal membrane with ATG8/LC3. Upon fusion with lysosomes, the inner
autophagosomal membrane and its content, including pathogens, is degraded. Viruses interfere with this process and either block autophagosome formation or
degradation by interacting with ATG6/BECLIN-1, which is contained in autophagosome forming PI3 kinase complexes (VPS34 as PI3 kinase, VPS15, ATG6/BECLIN-1 and
ATG14L) and autophagosome degrading (VPS34, VPS15, ATG6/BECLIN-1 and UVRAG) or degradation blocking (VPS34, VPS15, ATG6/BECLIN-1, UVRAG and Rubicon) PI3
kinase complexes.
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the limiting membrane of pathogen-containing vesicles,
macroautophagy engulfs pathogens with additional autop-
hagosome-derived membranes. The principal targets of
antibacterial autophagy are bacteria-containing vesicles,
bacteria associated with remnants of damaged vesicles,
and bacteria that have already escaped into the cytosol.
Once caught safely inside an autophagosome, the autop-
hagosomal double membrane restricts pathogen dispersal
and provides an additional barrier against potential
attempts of pathogens to manipulate cellular processes.
The autophagosomal membranes separate pathogens from
cytosolic resources and promote their lysosomal delivery.
TLR
NLR
RLR
E3 ligase
Extracellular
Cytosol
TLR
Ub
Ub
Ub
Ub
NDP52
Ub
p62
OPTN
Intact vesicle 
(glycans hidden)
Gal8
NDP52
Damaged vesicle 
(glycans exposed)
TLR
Lysosome
Autophagy
Ub
ATG8/ LC3
Key:
Ubiquitin
Glycan
Eat-me
signals
PRR
Danger recep tor
Cargo  recep tor
a
b
c
d
e
f
TRENDS in Immunology 
Figure 2. How autophagy and LC3-assisted phagocytosis defend cells against infection. Synergistic lines of defence prevent the entry of pathogens into the cytosol of host
cells. (a) LC3-assisted phagocytosis is triggered by Toll-like receptors (TLRs) and potentially other pattern recognition receptors (PRRs) in response to microorganisms that
are taken up by phagocytosis or that have actively invaded nonphagocytic cells. LC3-assisted phagocytosis requires a subset of autophagy genes for the labelling of
phagosomes with ATG8/LC3, which promotes their lysosomal delivery and the efficient killing of vesicular pathogens. (b) Damage to the limiting membrane of the
pathogen-containing vesicle, either accidental or caused by pathogens attempting to escape from the vesicle, exposes the cytosol to glycans previously hidden inside the
vesicle. (c) Cytosol-accessible glycans are detected by the danger receptor galectin-8, which, by recruiting the cargo receptor NDP52 (nuclear dot protein 52), triggers
autophagy. (d) Pathogens having escaped galectin-8-induced autophagy are met by yet another layer of PRRs in the cytosol. (e) A yet-to-be-identified E3 ubiquitin ligase
causes the ubiquitin-coating of invading bacteria. It remains to be established whether this ligase only targets membrane-associated or also free-floating bacteria, whether
it is a PRR, and also whether its substrate is of bacterial or host origin. (f) Ubiquitin-coated bacteria are targeted for autophagy by three apparently non-redundant cargo
receptors, that is, NDP52, p62, and optineurin.
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The ability of macroautophagy to restrict bacteria from
colonising the host cytosol has been demonstrated for
Streptococcus pyogenes [13] and Salmonella enterica ser-
ovar Typhimurium [14].
Bacteria-engulfing autophagosomes are created by the
core autophagy machinery and have features similar to
conventional autophagosomes [15]. Certain differences
nevertheless exist, for example the ability to engulf very
large cargo such as chains of S. pyogenes. Formation of such
giant autophagosomes requires the involvement of Rab7 at
early steps of autophagosome formation [16], which con-
trasts its role in canonical macroautophagy where Rab7
primarily participates in the fusion of autophagosomes
with lysosomes [17]. Antibacterial autophagosomes also
have the tendency to enwrap their cargo into onion-like
membrane layers [16,18,19], although the origin and func-
tional importance of these structures remain uncertain.
Selective autophagy of cellular cargo and invading
pathogens are related processes and, unsurprisingly, fol-
low similar principles. Selective autophagy relies on the
tagging of the prospective cargo with specific ‘eat-me’
signals, which often comprise polyubiquitin chains. Simi-
lar to protein aggregates that become ubiquitylated before
being engulfed by autophagosomes, bacteria that have
damaged their vesicular compartments, and are exposed
to the cytosol, can attract a dense polyubiquitin coat [20].
Little is known about the nature of this ubiquitin coat. For
example, it remains unknown which bacterial surface
proteins and/or host proteins in the bacterial proximity
are ubiquitylated. Of particular interest is the identity of
the E3 ubiquitin ligases that create the bacterial ubiquitin
coat. These ligases likely represent novel pattern recogni-
tion or danger receptors. Their identification would enable
a rigorous genetic assessment of the importance of the
ubiquitin coat for the cell-autonomous antimicrobial de-
fence. The strongest candidate so far is LRSAM1 (leucine-
rich, a sterile a motif), a RING (Really Interesting New
Gene) domain E3 ubiquitin ligase with leucine-rich repeats
required for the autophagy of S. typhimurium [21], but
whose role in generating the ubiquitin coat has not been
established. Additional pattern recognition receptors with
proposed or established affinity for peptidoglycan also
contribute to antibacterial autophagy. PGRP-LE (peptido-
glycan recognition protein-LE) restricts the growth of Lis-
teria monocytogenes in Drosophila, whereas NOD1
(Nucleotide-Binding Oligomerization Domain) and
NOD2 attack Gram-negative and -positive bacteria in
human cells, possibly by recruiting ATG16L1 to the site
of bacterial entry [22,23]. Mutant NOD2 alleles, found in
some patients with Crohn’s disease, fail to antagonise the
cytosolic growth of several bacteria, including adherent-
invasive Escherichia coli (AIEC), a bacterium associated
with ileal Crohn’s disease [24,25].
An alternative eat-me signal was recently identified,
when the recruitment of galectin-8 to damaged bacteria-
containing vesicles was found to restrict the intracellular
growth of S. typhimurium by triggering autophagy [5].
Galectins are b-galactoside-binding lectins that accumu-
late in the cytosol before being secreted in a leader-peptide-
independent manner [26]. Although galectins bind carbo-
hydrates of certain pathogens with high specificity [27],
S. typhimurium does not display ligands for galectin-8 [5].
The recruitment of galectin-8 to S. typhimurium rather
depends on the rupture of Salmonella-containing vesicles
(SCVs), which exposes host glycans previously hidden
inside the vesicles as ligands for galectin-8. Sterile damage
to endosomes or lysosomes also recruits galectin-8 to vesi-
cle remnants, as does damage caused by L. monocytogenes
or Shigella flexneri; two bacteria that actively invade the
cytosol as part of their life cycle. Galectin-8 is therefore a
danger receptor that, by surveying the integrity of the
endolysosomal compartment, serves as a versatile sentinel
for vesicle-damaging pathogens. The human genome
encodes about 12 galectins, of which galectin-1, galectin-
3 and galectin-9 are also recruited to damaged vesicles
[5,28,29]. The functional consequences of their recruitment
to membrane remnants remain to be identified.
The ubiquitin- and galectin-8-dependent eat-me signals
for selective autophagy are detected by adaptor proteins,
also known as autophagy or cargo receptors. These receptors
deploy LC3-interacting regions (LIRs) to direct cargo to
nascent LC3-positive phagophores. LIRs are short b-
strands, often preceded by a stretch of acidic amino acids,
which, via a W/FxxL/I consensus motif, bind to LC3/
GABARAP (GABA receptor-associated protein) family
members [30]. P62 (sequestosome 1 or SQSTM1), the
best-studied autophagy receptor, selects a variety of ubiqui-
tylated cargos, including protein aggregates, damaged mi-
tochondria, midbody rings and also ubiquitin-coated
bacteria for autophagy [18,30]. By contrast, the p62 para-
logue NBR1 (neighbour of the BRCA1 gene 1) is not required
to restrict the growth of S. typhimurium [18], but may
contribute to the autophagy attack against S. flexneri
[31]. NDP52 (nuclear dot protein 52) was identified in a
search for the ubiquitin-binding adaptor of TBK1 [32], a
major immunoregulatory kinase that restricts the intracel-
lular growth of S. typhimurium and S. pyogenes [33]. NDP52
recruits TBK1 (TANK-binding kinase) in complex with
SINTBAD (similar to NAP1 TBK1 adaptor) or NAP1
(NAK-associated protein 1) to cytosol-exposed bacteria by
detecting either a galectin-8 or a polyubiquitin eat-me signal
[5,32,34,35]. Binding of NDP52 to ubiquitin and galectin-8 is
mediated by its C-terminal zinc finger and an adjacent short
peptide, respectively, which distinguishes NDP52 as the
first autophagy receptor that responds to two types of eat-
me signals [5]. A third cargo receptor, optineurin, that also
detects ubiquitin-coated S. typhimurium, binds LC3 with
high affinity only if phosphorylated by TBK1 because it lacks
the negatively charged residues preceding the LIR motif in
other autophagy receptors [3].
Understanding the nonredundant contributions of
NDP52, p62 and optineurin to antibacterial autophagy
will be an interesting objective for future research. The
three receptors clearly differ in their ability to detect
unique eat-me signals associated with S. typhimurium,
such as galectin-8 and possibly distinct linkage types in the
bacterial ubiquitin coat [3]. Differential interactions with
eat-me signals are likely to cause the occurrence of NDP52,
p62 and optineurin in microdomains around S. typhimur-
ium, populated by either NDP52 or p62 [36], NDP52 and
optineurin but not p62 [3], or NDP52 and galectin-8 but not
p62 [5]. However, care must be taken when analysing
Review Trends in Immunology October 2012, Vol. 33, No. 10
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microdomains, because these are dynamic structures as
suggested by the recruitment of NDP52 to S. typhimurium
via galectin-8 and ubiquitin at early and later time points
post-infection, respectively [5].
Another feature distinguishing NDP52, p62 and opti-
neurin from each other might be their ability to recruit
selectively different effector molecules for the restriction of
bacterial growth. Such evidence has already been obtained
for TBK1, which is bound by optineurin and (indirectly) by
NDP52 but not by p62 [32,37]. A specific function of p62
might be the delivery of ubiquitylated cytosolic proteins to
autolysosomes, where they are proteolytically converted
into antimicrobial peptides [38,39]. None of the many other
p62 binding partners has an established role in antibacte-
rial autophagy. However, for the selective autophagy of
ubiquitylated protein aggregates, p62 recruits ALFY
(autophagy-linked FYVE protein), a 400-kDa protein that
binds ATG12–ATG5–ATG16L1 complexes and PI3P-con-
taining membranes. ALFY may therefore also be required
for antibacterial autophagy [40]. The potential recruitment
of ATG proteins other than LC3 and its paralogues by the
cargo receptors might explain how atg5/ or atg7/ cells
form autophagosome-like structure around S. typhimur-
ium, despite not being able to conjugate LC3 onto mem-
branes [15,18]. These LC3-negative structures are not
restricting bacterial growth, possibly because the closure
of antibacterial autophagosomes requires ATG8 paralo-
gue-dependent hemifusion activity [7,41]. In contrast to
cells deficient in the LC3-conjugation machinery, cells
lacking ATG9 or FIP200 (FAK-family interacting protein
200) fail to enclose S. typhimurium in autophagosomal
membranes. However, despite the absence of such mem-
branes, atg9/ or fip200/ cells still accumulate LC3
around the bacteria, probably by conjugating LC3 to the
damaged SCV membrane [15]. The current model of anti-
bacterial autophagy, in which NDP52, p62 and optineurin
link bacteria to LC3-positive phagophores, is therefore
simplistic and further work is required to understand
how distinct autophagy proteins are independently
recruited to cytosol-exposed bacteria.
Pathogen restriction by LC3-associated phagocytosis
and other noncanonical functions of ATG proteins
LC3 conjugated to PE, an invariant feature of canonical
macroautophagy, can also occur on single-membrane vesi-
cles. In a process called LC3-associated phagocytosis (LAP),
LC3 is recruited to certain phagosomes, for example, those
containing bacteria, where it promotes phagosome matura-
tion and fusion with lysosomes to enhance the antimicrobial
potential of phagocytosis [42]. LAP requires several proteins
that are also involved in canonical autophagy (BECLIN-1,
VPS34, ATG5, ATG7) but not others, such as for example
FIP200, a component of the ULK1 (UNC-51-like kinase 1)
kinase complex necessary for macroautophagy [42,43]. Ca-
nonical macroautophagy and LAP are therefore distinct
processes, both morphologically and mechanistically, that
nevertheless result in the accumulation of LC3 on vesicles.
The two pathways may even operate simultaneously and
electron microscopy is therefore required to distinguish
them with confidence. For example, upon treatment with
rapamycin or interferon (IFN)-g mycobacterial phagosomes
acquire LC3 and mature into phagolysosomes, consistent
with LAP [44]. However, electron microscopy has revealed
the simultaneous presence of additional onion-like multi-
lamellar structures typical for canonical macroautophagy
against bacterial targets.
Consistent with autophagy overcoming the maturation
block of mycobacterial autophagosomes and leading to
enhanced bacterial killing [44], experimental interference
with the delivery of LC3 to phagosomes may prevent the
killing of phagocytosed microbes, as demonstrated for
yeast in atg7/ macrophages [42]. A similar strategy is
used by Burkholderia pseudomallei, a Gram-negative bac-
terium causing melioidosis, which suppresses LAP by
secreting BopA and BpscN (TTSS effectors) into the mac-
rophage cytosol via its type III secretion apparatuses [45–
47]. How BopA and BspnN interfere with LAP remains
unknown. Recruitment of LC3 to microbe-containing pha-
gosomes requires Toll-like receptor (TLR) signalling from
within the vesicle, rather than from the cell surface, as
evidenced by the lack of LC3 conjugation to phagocytosed
latex beads if cells are exposed to LPS subsequent to the
phagocytic event [42]. Opsonisation can replace TLR sig-
nalling, and reactive oxygen species produced by NADPH
oxidases appear to be required for the targeting of LC3 to
phagosomes [48], which could result from autophagosome
fusion with phagosomes or from direct coupling of LC3 to
the phagosomal membrane. The generation of diacylgly-
cerol on Salmonella-containing vacuoles also triggers re-
cruitment of LC3, most likely during LAP, although
macroautophagy has not been formally excluded [49].
The ability of cells to distinguish phagosomes with
‘innocent’ and ‘infectious’ content may allow the preferen-
tial handling of infectious vesicles. In striking contrast to
the ability of macrophages to ignore phagocytosed latex
beads, macropinosomes and also whole cells in entotic
vesicles can be targeted by LC3 [43]. How the engulfment
of noninfectious cargo triggers LAP requires further inves-
tigations, although cells in entotic vacuoles may expose
phosphatidylserine before showing morphological signs of
cell death. The phosphatidylserine receptor TIM4 (T cell Ig
domain and mucindomain protein 4), which triggers LAP
in response to dead cells, may therefore be involved [43].
Experimentally curtailing the degradative potential of
phagosomes containing dead cells, for example, by pre-
venting LAP in atg7/ macrophages, leads to prolonged
macrophage activation and sustained production of proin-
flammatory cytokines [43]. Therefore, in addition to its
antimicrobial importance, LAP also contributes to the anti-
inflammatory potential of macrophages.
Another autophagosome-independent defence pathway
requiring at least one autophagy gene, atg5, occurs in
Toxoplasma gondii-infected macrophages stimulated with
IFN-g, whereupon ATG5-mediated recruitment of the im-
munity-related p47 GTPase IIGP1 (interferon-inducible
GTPase 1) the parasitophorus vacuole is destroyed and
the parasite killed [50].
These studies suggest that the autophagy machinery
contributes to the defence against pathogens in a variety of
ways, either by conventional macroautophagy or by deploy-
ing subsets of autophagy genes to accomplish the subcel-
lular trafficking of proteins or the maturation of organelles.
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Escape mechanisms of pathogens from autophagy-
mediated restriction
The ability of cells to defend themselves against invading
pathogens represents an ancient form of immunity preced-
ing the origin of multicellularity. In mammals, in which
ironically cell-autonomous immunity is best studied, sev-
eral lines of defence provide synergistic protection against
incoming pathogens. With respect to macroautophagy and
LAP, at least three classes of receptors detect invaders and
ensure their delivery to the lysosome: (i) extracellular and
endosomal pattern recognition receptors such as TLRs, (ii)
danger receptors surveying the integrity of the endolyso-
somal pathway such as galectin-8; and (iii) cytosolic pat-
tern recognition receptors such as NOD-like receptors
(NLRs). Although noninvasive bacteria, for example envi-
ronmental bacteria phagocytosed by lung macrophages,
will be safely destroyed, it is obvious how defects in certain
defence mechanisms can favour opportunistic pathogens.
Pathogens that invade the cytosol as part of their normal
life cycle, however, have to slip through all the nets. Much
can therefore be learnt from studying how professional
cytosol-dwelling pathogens avoid and inhibit cell-autono-
mous defence.
L. monocytogenes, a Gram-positive food-borne pathogen
that causes meningitis in immunocompromised individuals
and abortion in pregnant woman, is internalised by many
cell types. Using a pore-forming toxin and two lipolytic
enzymes, L. monocytogenes escapes from its vacuole into
the cytosol with high efficiency. Vacuolar damage by L.
monocytogenes is detected by galectin-3, -8 and -9, which
may trigger autophagy as bacteria transiently colocalise
with LC3 during invasion [5,28,29,51]. However, because
autophagy merely delays the onset of proliferation, L. mono-
cytogenes appears to escape the autophagic attack actively
[52]. Once in the cytosol, L. monocytogenes deploys ActA
(actin nucleator A), a cell surface protein and functional
analogue of host Wiskott-Aldrich syndrome protein (WASP)
proteins, for the recruitment of the actin-nucleating complex
Arp2/3 (actin related protein 2/3). Actin-driven mobility, a
feature of many cytosol-dwelling bacteria, favours the
spreading of bacteria into neighbouring host cells without
exposure to extracellular immune effectors. ActA prevents
the coating of L. monocytogenes with ubiquitin and thereby
interferes with cargo-receptor-mediated selective auto-
phagy, possibly because ActA-recruited host proteins dis-
guise the bacterial surface [20,53]. InlK (internalin-like K),
an internalin family member expressed mainly in vivo,
similarly conceals the presence of L. monocytogenes from
autophagy by coating the bacterial surface with MVP (major
vault protein), the major component of large cytosolic ribo-
nucleoprotein complexes called vaults [54]. In contrast to
mammals, in which L. monocytogenes colonises the cytosol
with the help of ActA and InlK, in Drosophila, L. mono-
cytogenes falls prey to autophagy due to the presence of
PGRP-LE, a cytosolic peptidoglycan receptor [22]. How
PGRP-LE triggers autophagy and whether it is a LIR-
motif-containing autophagy receptor remains unknown.
The vertebrate PGRP orthologues, called PGLYRPs, are
unlikely to be involved in autophagy because they function
extracellularly as peptidoglycan amidases and antimicrobi-
al proteins. Nevertheless, recognition of peptidoglycan
fragments still contributes to autophagy induction in mam-
malian cells because NOD1 and NOD2, the founding mem-
bers of the NLR family, recruit ATG16L1 to bacterial entry
sites [55].
In addition to its cytosolic lifestyle associated with
extensive proliferation, L. monocytogenes also occupies a
vesicular compartment, termed spacious Listeria-contain-
ing phagosomes (SLAPs). Bacteria in SLAPs proliferate at
a much lower rate, which may be associated with persis-
tent infections [14]. SLAPs are single membrane vesicles
positive for LC3 that are formed in a listeriolysin-O-depen-
dent manner; preferentially if toxin levels are suboptimal
for bacterial escape into the cytosol. Although the contri-
bution of autophagy to SLAP formation, possibly via the
LAP pathway, is not fully understood, SLAPs clearly rep-
resent a stalemate between autophagic attack and bacte-
rial countermeasures since bacterial hyperproliferation
occurs in atg5/ cells.
S. flexneri is a Gram-negative, enteroinvasive bacterium
that can cause severe colonic inflammation. Shigella
enforces its uptake into nonphagocytic cells with the help
of a type III secretion system, before escaping from its
vacuole into the cytosol. NOD1 and ATG16L1 are recruited
to the bacterial entry site [55], whereas the membrane
remnants of Shigella vacuoles are detected by galectin-3, -8
and -9, similar to the situation in Listeria-infected cells
[5,28,29]. The membrane remnants furthermore codistri-
bute with ubiquitin-, p62- and LC3-positive structures,
suggesting that they are targeted by selective autophagy
[28]. Once in the cytosol, Shigella deploys the autotran-
sporter IcsA (intracellular spread A) to recruit N-WASP
and Arp2/3, which provide the bacterium with actin-de-
pendent cytosolic mobility and the ability to spread from
cell to cell. However, IcsA and its biochemical activity are
also targets of cell-autonomous defence mechanisms. IcsA
is directly recognised by ATG5, which, unless outcompeted
by IcsB, restricts bacterial growth by targeting bacteria
into autophagosomes [19]. Septins, a family of GTP-bind-
ing cytoskeletal components, prevent actin-dependent mo-
bility and cell-to-cell spread by forming cages around
Shigella in an IcsA- and actin-polymerisation-dependent
manner [56]. Septin-encaged Shigella colocalises with
NDP52, p62 and LC3, suggesting they are targeted by
selective autophagy. A positive feedback between septin
cage formation and autophagy exists, because depletion of
SEPT2 or SEPT9 prevents p62 recruitment, whereas de-
pletion of p62 or core autophagy genes (atg5, atg6/beclin-1,
atg7) interferes with the entrapment of Shigella in septin
cages. The ability of S. flexneri and L. monocytogenes to
proliferate in the mammalian cytosol, despite facing a
multipronged immune attack, suggests the existence of
potent bacterial countermeasures that deserve to be eluci-
dated.
Macroautophagy assisting bacterial and viral replication
Vesicular compartments for bacterial replication and
release
Contrary to the mere avoidance of autophagy practiced by
L. monocytogenes and S. flexneri, other bacteria take active
advantage of the unique opportunities autophagy offers to
pathogens able to co-opt the pathway. These possibilities
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include the generation of vesicular compartments to
sustain bacterial replication and to allow unorthodox
trafficking.
Rather than being restricted by autophagy, a phyloge-
netically heterogeneous group of bacteria proliferate in
double- or multilamellar LC3+ vesicles, which most likely
represent canonical autophagosomes failing to acidify and
mature. Examples include Staphylococcus aureus [57,58],
Yersinia pseudotuberculosis [59], Yersinia pestis [60] and
Anaplasma phagocytophilum [61]. Except for Y. pestis,
which is impervious to the effects of autophagy, these
species fail to grow in atg5/ cells, whereas autophagy
induction by rapamycin enhances their proliferation. How
these bacteria co-opt autophagy and how autophagy con-
tributes to bacterial growth remains unknown.
Brucella abortus and Francisella tularensis deploy
autophagy not to foster their proliferation, but to travel
in an unorthodox manner within and out of their host cells.
B. abortus resides in the endosomal pathway for several
hours post-infection before acquiring ER markers includ-
ing membrane-bound ribosomes. Proliferation begins once
the ER-derived Brucella-containing vacuole (BCV) is
established. Bacterial spreading from cell to cell requires
conversion of the replicative BCV into an autophagosome-
like structure comprising multiple membranes but lacking
LC3 [62]. Consistent with these features, formation of
multi-lamellar BCVs is independent of atg4, atg7, atg5
and atg16l1 but requires upstream autophagy genes,
namely ulk1, beclin-1 and atg14l. LC3-negative double-
membrane structures, formed in an ATG5-independent
fashion, also engulf Mycobacterium marinum, an actin-
polymerising and therefore professionally cytosol-dwelling
species [63]. Conceivably, LC3-negative autophagosomes
can be formed if bacteria selectively engage only a subset of
autophagy genes and they may represent a physiological
pendant to alternative autophagy in atg5/ or atg7/
cells [64].
F. tularensis, a highly infectious bacterium that was
once included in biological warfare programs, replicates in
the cytoplasm of mammalian cells, suggesting it avoids
autophagy. Following replication, however, F. tularensis is
taken up into large double-membrane vacuoles, which
measure up to 15 mm in diameter, are positive for LC3
and contain multiple bacteria [65]. Although the replica-
tion of F. tularensis is not dependent on autophagy, expo-
sure to the low pH of autolysosomes may trigger the
expression of genes required for egress, reinfection or
extracellular life. Understanding how F. tularensis
switches from a state in which it avoids autophagy to a
state in which it induces autophagy could give important
insights into the mechanisms of antibacterial autophagy.
Membrane structures for viral replication
Shortly after the discovery of autophagosomes by electron
microscopy [66], autophagosome-like vesicles were noticed
in poliovirus infected cells [67]. Infection with this picor-
navirus leads to the accumulation of small double-mem-
brane surrounded vesicles in the perinuclear area of
infected cells, on which the virus assembles its replication
machinery. These vesicles contain cytosol, the lysosome
associated membrane protein 1 (LAMP1) and ATG8/LC3
[68]. Although the two poliovirus proteins 2BC and 3A
induce this vesicle accumulation, only 2BC is required to
lipidate ATG8/LC3. This extensive membrane reorganisa-
tion seems to be required for virus production, because
downregulation of macroautophagy via siRNA-mediated
silencing of either of the two ubiquitin-like molecules of
macroautophagy, ATG12 or ATG8/LC3A and B, results in
diminished virus replication [69]. Thus, poliovirus seems
to use at least parts of the macroautophagy machinery to
assemble membrane structures for its replication.
In addition to poliovirus, many other RNA viruses have
been suggested to interfere with membrane trafficking via
the molecular machinery of macroautophagy [70]. Howev-
er, for most of these viruses the relevance of this regulation
for their replication is still unresolved and in the case of
coronaviruses even controversial [71,72]. Thus, we focus in
this section on one other virus, which induces significant
membrane remodelling for its replication and uses macro-
autophagy to do this: the flavivirus hepatitis C virus
(HCV). The autophagic vesicles that accumulate in
HCV-infected hepatocytes fuse with each other and do
not accumulate as a multitude of small autophagosomes
as observed in poliovirus-infected cells [73]. Both ATG5
and ATG8/LC3 accumulate at the stabilised membrane
structures, which is suggested to result from a virus-in-
duced unfolded protein response (UPR) [74]. This hypoth-
esis is consistent with macroautophagy induction by UPRs
in yeast, which is thought to degrade expanded ER to
return affected cells to the physiological equilibrium
[75]. In addition, the HCV NS3 protein interacts with
the immunity-associated GTPase family M (IRGM), which
in turn interacts with ATG5, ATG10, ATG8/LC3 and
endophilin-1 (SH3GLB1) [76]. RNA silencing of several
essential atg products, namely ATG4, ATG5, ATG6/
BECLIN-1, ATG7, ATG8/LC3 and ATG12, as well as
IRGM, suppresses HCV replication [74,76,77]. Primarily,
translation of HCV RNA, shortly after infection seems to
depend on functional macroautophagy machinery [77].
Therefore, HCV also prevents fusion of autophagic mem-
branes with lysosomes to promote its own replication.
In addition to this membrane remodelling for viral
replication, another flavivirus, dengue virus, generates
energy for its replication via macroautophagy [78]. This
catabolic activity leads to the turnover of lipid droplets and
triglycerides via autophagosomes, generating free fatty
acids, from which ATP can be generated to benefit viral
replication. Thus, autophagy does not only generate mem-
brane compartments for viral replication, but also in part
the energy necessary to carry out virus production.
Viral release via macroautophagy
In addition to viral replication on autophagic membranes,
macroautophagy is involved in the generation of vesicular
structures, from which viruses are exported. This was
hypothesized initially for poliovirus [69]. Indeed, release
of this virus is increased if tethering of these autophagic
vesicles to the cytoskeleton is inhibited [79]. In this respect,
we will discuss two other viruses of interest to human
health, namely HIV and influenza virus. Both block autop-
hagosome maturation in infected cells [80,81]. In addition,
HIV downregulates autophagosome formation [82,83],
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whereas influenza virus boosts autophagic flux under cer-
tain circumstances [84,85]. HIV tat and interleukin (IL)-
10, produced by infected cells, have both been implicated in
auto- and paracrine inhibition of autophagosome forma-
tion [83], whereas HIV nef is involved in blocking autop-
hagosome fusion with lysosomes [80]. Interestingly, it
achieves this through interaction with ATG6/BECLIN-1
and IRGM [76,80]. This stabilisation of autophagic vesi-
cles, autophagosomes themselves or multivesicular bodies
(MVBs) that receive input from autophagosomes, aug-
ments virus production and release of infectious particles
[76,80]. RNA silencing of ATG6/BECLIN-1, ATG7 or IRGM
inhibits HIV particle release [76,80]. These studies suggest
that HIV inhibits autophagosome degradation in order to
replicate efficiently in myeloid cells.
Although influenza A virus also causes autophagosome
accumulation [76,81], it remains unclear how this affects
virus replication. Although one study has observed inhibi-
tion of influenza A virus replication upon RNA silencing of
ATG6/BECLIN-1 and ATG8/LC3 [84], two other studies
have reported no effect of silencing or deficiency of ATG5 on
macroautophagy [76,81]. However, the influenza A virus
protein matrix protein 2 (M2) blocks autophagosome fusion
with lysosomes and interacts with ATG6/BECLIN-1 [81].
This block of autophagosome maturation causes more cell
death in infected cells, which could facilitate influenza A
virus infection in vivo. Thus, HIV and influenza A virus
both block autophagosome fusion with lysosomes, but one
virus seems to benefit from this block for its own replica-
tion, whereas the other regulates host cell death via this
manipulation.
Irrespective of the underlying mechanism, macroauto-
phagy plays a crucial role for viral replication and protec-
tion from viral pathogenesis in vivo for several RNA and
DNA viruses. The RNA virus vesicular stomatitis virus
(VSV) replicates better in flies in the absence of macro-
autophagy [86]. In addition, the RNA virus Sindbis virus
replicates to similar levels in macroautophagy-deficient
neurons, but causes more pathology in ATG5-negative
brains [87], suggesting that macroautophagy ensures sur-
vival of infected host cells in vivo. Furthermore, the two
DNA viruses of the herpesvirus family, herpes simplex
virus (HSV) and mouse herpesvirus (MHV) 68 encode
inhibitors of macroautophagy, without which their infec-
tion in mice is compromised [88,89]. Along these lines, HSV
carries with ICP34.5 a viral gene product that binds ATG6/
BECLIN-1 and thereby prevents autophagosome forma-
tion [88]. Furthermore, MHV blocks ATG3 and ATG6/
BECLIN-1 with its viral FLIP [FLICE (Caspase-8)-inhibi-
tory protein] and Bcl-2 (B Cell CLL/Lymphoma) gene
products, respectively [89,90]. Interestingly, especially
the neurovirulence of both Sindbis virus and HSV is com-
promised by macroautophagy. For these two viruses, p62/
sequestosome and possibly its recruitment via SMURF1
(SMAD-specific E3 ubiquitin protein ligase 1) have been
implicated in the recruitment of these pathogens to autop-
hagosomes [4,87]. These studies suggest that macroauto-
phagy can target viral particles and proteins. However, as
with bacterial pathogens, successful viruses that cause
disease have developed immune escape mechanisms from
macroautophagy in their respective hosts. All viruses have
a cytosolic stage of their replication cycle, thus, most of
them manipulate autophagosome formation or degrada-
tion. These escape mechanisms are host species adapted,
therefore, the strongest protective effects of macroauto-
phagy can be observed in experimental hosts, for example,
in the case of the bird- and mosquito-adapted Sindbis virus
in mice.
Regulation of innate cytokine production by
macroautophagy
Besides this direct role of macroautophagy in pathogen
restriction, macroautophagy has also been shown to influ-
ence innate cytokine production, although so far the con-
tribution of this regulation to resistance or susceptibility to
pathogens has not been firmly established. Along these
lines, macroautophagy can transport viral replication
intermediates into endosomes that carry TLRs [91].
TLR-mediated type I IFN production by Sendai virus or
VSV-infected plasmacytoid dendritic cells (DCs) depends
on macroautophagy. By contrast, parts of the molecular
macroautophagy machinery seem to inhibit type I IFN
production following cytosolic RNA sensor stimulation
[92,93]. Increased reactive oxygen species production or
the ATG5–ATG12 complex itself seems to inhibit RIG-I
activation. In addition to type I IFN, IL-1 production is also
influenced by macroautophagy. Macrophages deficient in
this pathway secrete much more of this proinflammatory
cytokine upon stimulation [94]. In part, this enhanced IL-1
production results from inflammasome activation by dam-
aged mitochondria, which are no longer degraded by this
pathway [95], and decreased inflammasome degradation
via autophagosomes [96]. These studies suggest that
macroautophagy regulates at least some inflammatory
cytokines, which restrict pathogens by innate immune
responses and shape adaptive immune responses.
Macroautophagy during adaptive immune responses
Antigen processing via macroautophagy
Both humoral and cell-mediated adaptive immune
responses hinge on the efficient induction of helper T cell
responses, which play an essential role in antibody affinity
maturation and cytotoxic T cell maintenance. Helper T
cells recognise antigen fragments presented on MHC class
II molecules, which are predominantly generated by lyso-
somal hydrolysis. Around 20–30% of the MHC class II
presented ligands are derived from cytosolic and nuclear
antigens [97], suggesting an intracellular antigen proces-
sing pathway for MHC class II loading. Among these
ligands, self-protein-derived peptides can be found, some
of which originate from the mammalian ATG8 homologues
LC3 and GABARAP [97,98]. Further evidence that macro-
autophagy contributes to MHC class II loading of cytosolic
and nuclear antigens was provided by the characterisation
of the MHC class II derived natural ligand repertoire of
starved Epstein–Barr virus (EBV)-transformed B cells
(LCLs) [97]. LCLs upregulate macroautophagy after star-
vation, and under these conditions, MHC class II presen-
tation of cytosolic and nuclear antigens was upregulated by
50%, whereas presentation of membrane-bound protein
fragments was not affected. Furthermore, autophago-
somes have been found frequently to fuse with late
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endosomal MHC class II containing compartments
(MIICs), in which antigen is loaded onto MHC class II
molecules [99,100] (Figure 3). Moreover, targeting of anti-
gens to autophagosomes via fusion to the N terminus of
ATG8/LC3 enhances their presentation on MHC class II
molecules to CD4+ T cells [85,99]. These studies suggest
that autophagosomes deliver intracellular substrates for
MHC class II loading in a wide variety of cell types,
including DCs, B cells and epithelial cells.
In addition to self-proteins, this antigen processing
pathway has been suggested to deliver pathogen-derived
antigens for MHC class II loading. Two of these have been
investigated in more detail in several studies. The first is
the nuclear antigen 1 of EBV (EBNA1). This protein
ensures replication of the viral genome in the nucleus prior
to host cell division and anchors EBV DNA to mitotic
chromosomes during mitosis to ensure viral maintenance
in replicating cells. It carries a glycine–alanine repeat
domain that protects it from proteasomal degradation
[101,102], and accumulates upon lysosomal inhibition
[103]. In addition, it is presented to CD4+ T cells after
intracellular processing [104]. This processing is mediated
by macroautophagy, because EBNA1 accumulates in
autophagosomes after lysosomal inhibition, and RNA si-
lencing of macroautophagy decreases CD4+ T cell recogni-
tion of EBV-infected B cells [103,105]. This intracellular
antigen processing of EBNA1 for MHC class II presenta-
tion via macroautophagy is enhanced, when the nuclear
import of EBNA1 is compromised [105]. These studies
suggest that a cytosolic pool of EBNA1, either prior to
import into the nucleus or liberated after dissociation of the
nuclear envelope during mitosis gains access to intracellu-
lar MHC class II antigen processing by macroautophagy. A
second antigen for macroautophagic processing towards
MHC class II presentation to CD4+ T cells is the bacterial
transposon-derived neomycin phosphotransferase II
(NeoR) [85,106]. MHC class II presentation of this antigen
by transfected cells to a specific CD4+ T cell clone is
sensitive to macroautophagy inhibition [106], and antigens
fused to NeoR are more efficiently presented on MHC class
II molecules [85]. In contrast to EBNA1, however, nuclear
localisation of NeoR after insertion of a nuclear import
sequence does not compromise macroautophagy-depen-
dent antigen processing, and even slightly improves
MHC class II presentation [107]. Thus, it is not nuclear
localisation in general, but maybe subcompartmentalisa-
tion in this organelle that determines accessibility of anti-
gens to macroautophagic antigen processing for MHC class
II presentation.
In addition to intracellular antigen processing, macro-
autophagy might also play a role in extracellular antigen
processing for MHC class II presentation. This suggestion
is based on a study in mice with macroautophagy deficiency
after atg5 knockout in CD11c-positive cells, (mostly DCs)
[108]. In addition to diminished CD4+ T cell responses after
HSV infection in these mice, addition of soluble ovalbumin
(OVA) or OVA-coated splenocytes resulted in decreased
MHC class II, but unaffected MHC class I presentation to
specific T cell receptor (TCR) transgenic T cells. Thus, the
authors suggested that, in addition to intracellular antigen
processing for MHC class II presentation after HSV or
recombinant Listeria infection, macroautophagy also con-
tributes to extracellular antigen processing for CD4+ T cell
stimulation. This correlates with diminished maturation of
phagosomes, possibly resulting from slower fusion with
lysosomes. This phenotype would fit with three studies
showing a role for parts of the macroautophagy machinery
in phagosome fusion with lysosomes (LAP), suggesting
ATG8/LC3-dependent facilitation of this fusion event
[42,43,109]. Alternatively, autophagosome cargo could ren-
der phagosomes more processive by delivering hydrolases
to these vesicles through fusion. Along these lines, it has
recently been shown that citrullination, a post-translation-
al modification detected on some autoantigens and facili-
tating their immune recognition, for example, during
rheumatoid arthritis, depends on macroautophagy [110].
More specifically, the peptidylarginine deiminase (PAD)
responsible for citrullination of endocytosed proteins was
only able to reach phagosomes via autophagosomes. There-
fore, fusion of phagosomes with lysosomes and composition
of phagosomal content could be modified by macroauto-
phagy to result in more efficient extracellular antigen
processing onto MHC class II molecules.
Lymphocyte education via macroautophagy
Another physiological setting, in which antigen processing
via macroautophagy might be particularly important is T
cell education in the thymus. In order to shape a useful and
self-tolerant T cell repertoire, developing T cells are edu-
cated to recognize self-MHC molecules in the thymic cortex
in a process called positive selection. In addition, self-
reactive T cell specificities are eliminated in the thymic
medulla via negative selection [111]. Thymic epithelial
cells (TECs) interact with the developing T cells in these
two processes and express both MHC class I and II mole-
cules for this purpose. In order to display peptides not just
derived from thymic proteins during these processes, TECs
also express at low levels peripheral-organ-specific pro-
teins with the help of the transcription factor autoimmune
Auto-
phagosome
Phagosome
MIIC
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class  II 
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Figure 3. Antigen for major histocompatibility complex (MHC) class II presentation
can be provided by phagocytosis or macroautophagy. Cytosolic pathogens are
delivered to MHC class II containing compartments (MIICs) via macroautophagy
for antigen loading. Extracellular pathogens reach this MHC class II loading
compartment via endocytosis, which might be in some instances be facilitated by
ATG8/LC3 coupled to the phagosome.
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regulator (AIRE) [112]. However, for processing of these
proteins towards MHC class II presentation, it is suggested
that TECs require intracellular pathways, because they
are poorly endocytic [113]. Along these lines, a role for
macroautophagy in both of these processes was then de-
fined [114]. During positive selection of TCR transgenic T
cells in atg5-deficient thymuses, some CD4+ T cell specifi-
cities were efficiently selected, whereas positive selection
of others was compromised, probably due to insufficient
MHC class II presentation of the positively selecting pep-
tide ligands. By contrast, positive CD8+ T cell selection was
unaffected. Furthermore, negative selection of a wild-type
precursor repertoire through atg5-negative thymic trans-
plants in thymus-deficient nude mice resulted in autoreac-
tive T cells, causing autoimmune colitis and lymphocyte
infiltration in other organs, including Harderian glands,
uterus, liver and lung. In agreement with these findings,
autophagosomes were found frequently to fuse with MIICs
in TECs [115]. These findings suggest that intracellular
proteins are presented on MHC class II molecules of TECs
after macroautophagy, and that the T cell repertoire is
altered in the absence of this process. Of particular interest
is the fact that such an altered T cell repertoire contains
specificities that mediate autoimmune colitis, reminiscent
in its manifestation of Crohn’s disease. Indeed mutations
have been found associated with the familial form of this
autoimmune disease of the digestive tract in two proteins
linked to macroautophagy, namely ATG16L1 and IRGM
[116–119]. Furthermore, the Crohn’s disease associated
ATG16L1 variants have been shown to compromise
MHC class II restricted antigen presentation of DCs ma-
tured with NOD2 ligands [24], and NOD2 is another risk
locus for this disease [120,121]. Therefore, it is tempting to
speculate that also in humans compromised macroauto-
phagy in the thymus might allow the development of an
autoimmune T cell repertoire that could contribute to
Crohn’s disease.
Lymphocyte survival via macroautophagy
In addition to this antigen processing function of macro-
autophagy that shapes lymphocyte repertoires, this path-
way plays also a role during lymphocyte development and
responses. Haematopoietic progenitor cells (HPCs) rely on
this process for their maintenance [122,123]. In its ab-
sence, myeloproliferation develops, seemingly because
both T and B cell lineage development is compromised.
By contrast, plasmacytoid and conventional DC develop-
ment is unaffected by loss of macroautophagy [91,108].
Both T cell development and proliferation during immune
responses are compromised in the absence of macroauto-
phagy [124]. Several mechanisms are responsible for these
T cell defects in the absence of macroautophagy. For one,
mature T cells need to decrease their mitochondria content
during transition from the thymus to the periphery. Macro-
autophagy deficiency prevents this due to loss of mitochon-
dria degradation. This leads to increased levels of reactive
oxygen species, which compromises the survival of T cells
without macroautophagy [125]. In addition, macroauto-
phagy-deficient T cells cannot efficiently mobilize Ca2+
upon TCR stimulation, resulting in impaired activation
[126]. Therefore, macroautophagy is required for T cell
development and function. A less severe, but also detect-
able dependency of B cell development and maintenance on
macroautophagy has been identified. B cell precursor sur-
vival in the bone marrow is affected by loss of macroauto-
phagy, particularly at the pro- to pre-B cell transition
[127,128]. Mature B cells, in contrast, are mostly unaffect-
ed by macroautophagy loss for their survival. Only the
innate B-1a subset is compromised in its maintenance by
macroautophagy deficiency [128]. Therefore, lymphocytes,
but not leukocytes in general, need macroautophagy for
their development and survival. Selective lymphocyte
lineages are more affected than others by macroautophagy
deficiency, and the role of macroautophagy in cell organelle
homeostasis, primarily mitochondria and ER turnover, is
required during lymphocyte development and their im-
mune responses.
Concluding remarks
Autophagy, particularly macroautophagy, has emerged as
an important cellular pathway for pathogen restriction and
replication, as well as antigen processing. Recent studies
show how pathogens that escape endosomes are imported
into autophagosomes and how pathogens adapted to life in
the cytosol have evolved escape mechanisms from macro-
autophagic degradation. In its coevolution with pathogens,
the adaptive immune system of higher eukaryotes has also
learned to utilise macroautophagy. Autophagy provides
peptides for presentation on MHC molecules from self-
antigens and pathogens during thymic selection and dur-
ing peripheral immune responses, respectively. Therefore,
as with classical phagocytosis, macroautophagy has
evolved from a nutrient-providing pathway to fulfil addi-
tional effector mechanisms of innate, cell-intrinsic and
adaptive immunity in higher eukaryotes.
The role of the molecular macroautophagy machinery
during infection and immune responses may extend even
further. At least some ATG proteins are involved in phago-
cytosis by modulating phagosome maturation and in exo-
cytosis of signal-peptide-lacking substrates [129–131],
possibly even whole virions and exosomes [132,133]. This
alternative use of macroautophagy modules needs to be
better understood in order to harness pathogen restriction
by macroautophagy therapeutically without boosting path-
ogen replication.
Furthermore, macroautophagy plays a role in MHC
class II ligand generation for T cell education and intra-
cellular antigen processing for CD4+ T cell recognition. In
addition, this pathway might also influence the compart-
mentalisation of antigen to vesicles or protein aggregates,
which allow processing towards MHC class I presentation
for CD8+ T cell responses [134–136]. The nature of these
MHC class I antigen compartments and how macroauto-
phagy regulates them needs to be more clearly defined in
order to use them for efficient induction of immune
responses after vaccination.
The importance of canonical macroautophagy in
pathogen infection and immune responses is now well
established. Alternative deployment of parts of the macro-
autophagy machinery seems to have an impact on an even
wider spectrum of cell biological processes for the benefit or
restriction of invading microbes. These later areas, in
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particular, constitute a fruitful field of investigation for the
near future.
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